Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (DRKS00040894) titled 'The Underestimated Side Effect: Financial Toxicity in Metastatic Breast Cancer-A Single-Center Cross-Sectional Study' on July 31.
Study Type: observational
Study Design:
Allocation:
Masking:
Control:
Assignment:
Study design purpose: health services research
Primary Sponsor: Universitatsklinikum Schleswig-Holstein, Campus Kiel, Klinik fur Gynakologie und Geburtshilfe
Condition:
C50.9
Malignant neoplasm: Breast, unspecified
Intervention:
Group 1: Observational group: patients with metastatic breast cancer receiving ongoing systemic anticancer therapy
Recruitment Status: Not Recruiting
Date of First Enrollment...